Walter E DeWolf, Jr

Title: Innovations of Walter E DeWolf, Jr.

Introduction

Walter E DeWolf, Jr. is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and polynucleotides. With a total of three patents to his name, DeWolf's work has implications for both antibacterial screening and diagnostic methods.

Latest Patents

One of his latest patents involves the FabK variant, which provides FabK polypeptides and polynucleotides encoding these polypeptides. This invention outlines methods for producing such polypeptides through recombinant techniques. Additionally, it includes methods for utilizing FabK polypeptides to screen for antibacterial compounds. Another aspect of the FabK variant patent focuses on using these polypeptides and polynucleotides as diagnostic reagents in assays to screen for microbial infections in organisms and infestations in materials.

Career Highlights

Walter E DeWolf, Jr. is currently associated with Affinium Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceuticals. His work is characterized by a commitment to advancing medical science through his inventions.

Collaborations

Some of his notable coworkers include David John Payne and Nicola Gail Wallis, who contribute to the collaborative environment that fosters innovation at Affinium Pharmaceuticals.

Conclusion

Walter E DeWolf, Jr. exemplifies the spirit of innovation in biotechnology through his patents and contributions to the field. His work not only advances scientific knowledge but also has practical applications in healthcare.